Yahoo Web Search

Search results

    • Small Business - The Andalusia Star-News | The Andalusia Star-News

      The Andalusia Star-News· 11 hours ago

      Phase 2 data for ERLEADA® (apalutamide) plus androgen deprivation therapy following radical prostatectomy in patients with high-risk localized prostate cancer show 100% biochemical free recurrence rate more than two years post-surgery PR Newswire SAN